The Venture Codex Logo

The Venture Codex

3E Bioventures Capital

1 First Street Suite 18, Los Altos, California, 94022, United States

Overview

Healthcare-focused venture investment fund for early-stage companies.

Founded

2015

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

China
United States

Sector focus

Financial Services
Health Care
Medical
Venture Capital

Investment portfolio

34rounds
NAMEDATESIZE
OncoC4
Oct 2025Participated
$50 MSeries B
Rapafusyn Pharmaceuticals
Sep 2025Participated
$44 MSeries A
Arnatar Therapeutics
Aug 2025Led
$52 MSeries A
Acclaro Medical
May 2025Participated
$23 MSeries B
Rapafusyn Pharmaceuticals
Jun 2024Led
$28 MSeries A
Cellbri
Jun 2024Led
$28 MSeries B
varnotech
Mar 2024Participated
$83 MSeries B
Myrobalan Therapeutics
Jan 2024Participated
$24 MSeries A
Jushu Biotech
Nov 2023Participated
$14 MSeries A
Smartlens
Jul 2023Participated
$6 MSeries A
Larkspur Biosciences
May 2023Led
$36 MOther Equity
Eluminex Biosciences
Feb 2023Participated
$40 MSeries B
OncoC4
Oct 2025Participated
$50 MSeries B
Rapafusyn Pharmaceuticals
Sep 2025Participated
$44 MSeries A
Arnatar Therapeutics
Aug 2025Led
$52 MSeries A
Acclaro Medical
May 2025Participated
$23 MSeries B
Rapafusyn Pharmaceuticals
Jun 2024Led
$28 MSeries A
Cellbri
Jun 2024Led
$28 MSeries B
varnotech
Mar 2024Participated
$83 MSeries B
Myrobalan Therapeutics
Jan 2024Participated
$24 MSeries A
Jushu Biotech
Nov 2023Participated
$14 MSeries A
Smartlens
Jul 2023Participated
$6 MSeries A
Larkspur Biosciences
May 2023Led
$36 MOther Equity
Eluminex Biosciences
Feb 2023Participated
$40 MSeries B
34
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

3E Bioventures Capital: 34 funding rounds are recorded in the selected participation categories.All available history.
3E Bioventures Capital: 34 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A87
Series B39
Series C+24
Other Equity10

Monthly Deal Activity

3E Bioventures Capital: 34 deals are recorded across 131 months.All available history.
3E Bioventures Capital: 34 deals are recorded across 131 months. All available history
MonthDeals
Dec '151
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '161
Oct '160
Nov '160
Dec '160
Jan '171
Feb '170
Mar '170
Apr '171
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '182
Jun '180
Jul '180
Aug '182
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '201
Apr '200
May '200
Jun '201
Jul '200
Aug '200
Sep '202
Oct '200
Nov '201
Dec '200
Jan '211
Feb '211
Mar '210
Apr '210
May '211
Jun '210
Jul '210
Aug '211
Sep '210
Oct '210
Nov '210
Dec '212
Jan '221
Feb '221
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '231
Mar '230
Apr '230
May '231
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '241
Feb '240
Mar '241
Apr '240
May '240
Jun '242
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '251
Sep '251
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

3E Bioventures Capital: Health & Life Sciences is the largest displayed sector by deal count (32 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

3E Bioventures Capital: Health & Life Sciences is the largest displayed sector by deal count (32 deals). All available history
SectorDeals
Health & Life Sciences32
Manufacturing3
Space & Frontier Tech3
Networks, Cloud & Communication2
Professional Services2
Consumer & Lifestyle2
E-Commerce & Retail1
AI & Machine Learning1

Deal Size Distribution

3E Bioventures Capital: 34 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

3E Bioventures Capital: 34 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M3
$10M-$25M9
$25M-$50M9
$50M-$100M10
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

3E Bioventures Capital: United States has the largest recorded deal count among the displayed regions (24 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

3E Bioventures Capital: United States has the largest recorded deal count among the displayed regions (24 deals). All available history
RegionDeals
United States24
China9
Canada1
3E Bioventures Capital: 20 co-investors are shown, with Yonjin Capital sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

3E Bioventures Capital: 20 co-investors are shown, with Yonjin Capital sharing 5 recorded deals. All available history
Co-investorShared deals
Yonjin Capital5
Cobro Ventures3
Taiwania Capital3
Decheng Capital2
GBA Fund2
HM Capital2
Kaitai Capital2
Lapam Capital2
Lilly Asia Ventures2
Med-Fine Capital2
Proxima Ventures2
VI Ventures2
3SBio1
AB Magnitude Ventures Group1
Accelmed1
Adage Capital Management1
Ambit Health Ventures1
ARCH Venture Partners1
Asset Management Ventures1
Atinum Investment1

Investment Strategy

3E Bioventures Capital: Led accounts for 41% and participating for 59% of round participation.All available history.
3E Bioventures Capital: Led accounts for 41% and participating for 59% of round participation. All available history
CategoryDeals (count)Share (%)
Led1441%
Participating2059%
3E Bioventures Capital: Single-lead accounts for 64% and co-led for 36% of lead dynamics.All available history.
3E Bioventures Capital: Single-lead accounts for 64% and co-led for 36% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead964%
Co-led536%

Team

Karen Liu

Founding Partner

Lue Sun

Vice President